Integra LifeSciences CEO Jan De Witte to retire by end of 2024; Stuart Essig named Executive Chairman

INTEGRA LIFESCIENCES HOLDINGS CORP

Jan De Witte to retire as President and CEO by end of 2024 after successor appointed; will remain until transition.
Stuart Essig, current Chairman, appointed Executive Chairman effective immediately to lead transition.
Board engaged Heidrick & Struggles to search for new CEO candidate; expects to appoint successor by end of 2024.
De Witte to serve as Senior Advisor from transition date through March 2026 under consulting agreement with base salary and bonus eligibility.
De Witte's retirement is for personal reasons, not due to disagreement with company operations or policies.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Stuart M. Essig

Executive Chairman

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Effective: 2024-02-28
Filed: February 28, 2024, 6:59 PM ET

On February 27, 2024, the Company’s Board of Directors appointed Stuart M. Essig, Ph.D., the Company’s Chairman, to the role of Executive Chairman, effective immediately.

Departed

Jan De Witte

President and Chief Executive Officer

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Filed: February 28, 2024, 6:59 PM ET

On February 27, 2024, Jan De Witte informed Integra LifeSciences Holdings Corporation (the “Company”) of his intention to retire from his position as President and Chief Executive Officer and director of the Company following the completion of a succession process.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stuart M. Essig was appointed as Executive Chairman at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: appointed
Role: Executive Chairman

Exact text from the filing

On February 27, 2024, the Company’s Board of Directors appointed Stuart M. Essig, Ph.D., the Company’s Chairman, to the role of Executive Chairman, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jan De Witte departed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: retire
Role: President and Chief Executive Officer

Exact text from the filing

On February 27, 2024, Jan De Witte informed Integra LifeSciences Holdings Corporation (the “Company”) of his intention to retire from his position as President and Chief Executive Officer and director of the Company following the completion of a succession process.

View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-24-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.